Clinical Trials Directory

Trials / Terminated

TerminatedNCT05229744

Prevalence of Endolymphatic Hydrops With a Hitory of Congenital Cytomegalovirus Infection

Prevalence of Endolymphatic Hydrops in Patients With a History of Congenital Cytomegalovirus Infection With Symptomatic Cochleo-vestibular Involvement

Status
Terminated
Phase
Study type
Observational
Enrollment
18 (actual)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
All
Age
6 Months
Healthy volunteers
Not accepted

Summary

The management of patients with a history of congenital CMV infection (whether symptomatic or asymptomatic at birth) is modeled on their usual management.

Detailed description

The management of patients with a history of congenital CMV infection (whether symptomatic or asymptomatic at birth) is modeled on their usual management. Patients benefit as part of the care: * A clinical cochleo-vestibular examination * Functional otoneurological explorations: audiogram, caloric tests, vHIT, otolithic evoked potentials * From an uninjected brain MRI Participation in this research entails the addition of an MRI sequence and an injection of contrast product (Gadovist®): \- 3D FLAIR MRI sequence dedicated to the exploration of the inner ear, lasting 6min30s, performed 4 hours after the initial injection of contrast product.

Conditions

Interventions

TypeNameDescription
DEVICEsequence MRI 3D FLAIRParticipation in this research entails the addition of an MRI sequence and an injection of contrast product (Gadovist®): \- 3D FLAIR MRI sequence dedicated to the exploration of the inner ear, lasting 6min30s, performed 4 hours after the initial injection of contrast product

Timeline

Start date
2022-12-15
Primary completion
2025-04-22
Completion
2025-04-22
First posted
2022-02-08
Last updated
2026-01-06

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05229744. Inclusion in this directory is not an endorsement.

Prevalence of Endolymphatic Hydrops With a Hitory of Congenital Cytomegalovirus Infection (NCT05229744) · Clinical Trials Directory